Literature DB >> 7924076

On the pathogenesis of multiple sclerosis. A revised model of the cause(s) of multiple sclerosis, especially based on epidemiological data.

J M Minderhoud1.   

Abstract

Data from an epidemiological study are used to analyse the course of multiple sclerosis. It could be proved that the course of MS is not as haphazard as was often supposed. In general the course is described as being a chronic progressive one, in the majority of patients preceded by a relapsing-remitting period. In contrast to the relapsing-remitting phase the chronic progressive phase of the course does not show marks of being an autoimmune process. From recent data obtained by MRI and NMR spectroscopy it can be concluded that the chronic progression of handicaps in multiple sclerosis is related to neuronal and axonal damage. The relation between these different pathogenetic processes should be the aim of further research.

Entities:  

Mesh:

Year:  1994        PMID: 7924076     DOI: 10.1016/0303-8467(94)90047-7

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  4 in total

1.  Natural history of multiple sclerosis.

Authors:  G C Ebers
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-12       Impact factor: 10.154

2.  Interferon-gamma activated calcium influx in peripheral blood lymphocytes from patients with primary and secondary progressive multiple sclerosis.

Authors:  G Martino; E Brambilla; M Filippi; V Martinelli; B Colombo; M Rodegher; G Comi; L M Grimaldi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-11       Impact factor: 10.154

3.  Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis.

Authors:  P J Jongen; K J Lamers; W H Doesburg; W A Lemmens; O R Hommes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-10       Impact factor: 10.154

4.  Demyelinating plaques in relapsing-remitting and secondary-progressive multiple sclerosis: assessment with diffusion MR imaging.

Authors:  A Castriota Scanderbeg; F Tomaiuolo; U Sabatini; U Nocentini; M G Grasso; C Caltagirone
Journal:  AJNR Am J Neuroradiol       Date:  2000-05       Impact factor: 4.966

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.